Literature DB >> 10956316

Managing cardiovascular risk in patients with diabetes.

L Rydén1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10956316      PMCID： PMC1766523          DOI： 10.1136/heart.84.suppl_1.i23

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  10 in total

1.  Diabetes and decline in heart disease mortality in US adults.

Authors:  K Gu; C C Cowie; M I Harris
Journal:  JAMA       Date:  1999-04-14       Impact factor: 56.272

2.  Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group.

Authors:  J D Curb; S L Pressel; J A Cutler; P J Savage; W B Applegate; H Black; G Camel; B R Davis; P H Frost; N Gonzalez; G Guthrie; A Oberman; G H Rutan; J Stamler
Journal:  JAMA       Date:  1996-12-18       Impact factor: 56.272

3.  The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

Authors:  M Coutinho; H C Gerstein; Y Wang; S Yusuf
Journal:  Diabetes Care       Date:  1999-02       Impact factor: 19.112

4.  Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study.

Authors:  K Malmberg; A Norhammar; H Wedel; L Rydén
Journal:  Circulation       Date:  1999-05-25       Impact factor: 29.690

5.  Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators.

Authors:  R B Goldberg; M J Mellies; F M Sacks; L A Moyé; B V Howard; W J Howard; B R Davis; T G Cole; M A Pfeffer; E Braunwald
Journal:  Circulation       Date:  1998-12-08       Impact factor: 29.690

6.  Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial.

Authors:  J Stamler; O Vaccaro; J D Neaton; D Wentworth
Journal:  Diabetes Care       Date:  1993-02       Impact factor: 19.112

7.  Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)

Authors:  K Pyŏrälä; T R Pedersen; J Kjekshus; O Faergeman; A G Olsson; G Thorgeirsson
Journal:  Diabetes Care       Date:  1997-04       Impact factor: 19.112

8.  Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

Authors:  L Hansson; A Zanchetti; S G Carruthers; B Dahlöf; D Elmfeldt; S Julius; J Ménard; K H Rahn; H Wedel; S Westerling
Journal:  Lancet       Date:  1998-06-13       Impact factor: 79.321

9.  Sixteen-year coronary mortality in black and white men with diabetes screened for the Multiple Risk Factor Intervention Trial (MRFIT).

Authors:  O Vaccaro; J Stamler; J D Neaton
Journal:  Int J Epidemiol       Date:  1998-08       Impact factor: 7.196

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.